Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 4
1969 5
1970 5
1973 1
1977 1
1978 1
1979 1
1983 5
1984 1
1985 4
1986 1
1987 6
1991 4
1992 2
1993 4
1994 7
1995 3
1996 3
1997 1
1998 5
1999 5
2000 4
2001 1
2002 3
2003 2
2004 1
2006 2
2007 3
2008 2
2009 3
2010 1
2011 2
2012 1
2013 2
2015 1
2016 3
2017 1
2018 2
2019 6
2020 3
2021 3
2022 7
2023 13
2024 12
2025 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

146 results

Results by year

Filters applied: . Clear all
Page 1
Genomic Classification and Individualized Prognosis in Multiple Myeloma.
Maura F, Rajanna AR, Ziccheddu B, Poos AM, Derkach A, Maclachlan K, Durante M, Diamond B, Papadimitriou M, Davies F, Boyle EM, Walker B, Hultcrantz M, Silva A, Hampton O, Teer JK, Siegel EM, Bolli N, Jackson GH, Kaiser M, Pawlyn C, Cook G, Kazandjian D, Stein C, Chesi M, Bergsagel L, Mai EK, Goldschmidt H, Weisel KC, Fenk R, Raab MS, Van Rhee F, Usmani S, Shain KH, Weinhold N, Morgan G, Landgren O. Maura F, et al. Among authors: papadimitriou m. J Clin Oncol. 2024 Apr 10;42(11):1229-1240. doi: 10.1200/JCO.23.01277. Epub 2024 Jan 9. J Clin Oncol. 2024. PMID: 38194610 Free PMC article.
Impact of soluble BCMA and non-T-cell factors on refractoriness to BCMA-targeting T-cell engagers in multiple myeloma.
Lee H, Durante M, Skerget S, Vishwamitra D, Benaoudia S, Ahn S, Poorebrahim M, Barakat E, Jung D, Leblay N, Ziccheddu B, Diamond B, Papadimitriou M, Cohen AD, Landgren O, Neri P, Maura F, Bahlis NJ. Lee H, et al. Among authors: papadimitriou m. Blood. 2024 Dec 19;144(25):2637-2651. doi: 10.1182/blood.2024026212. Blood. 2024. PMID: 39321344 Free PMC article.
Biallelic antigen escape is a mechanism of resistance to anti-CD38 antibodies in multiple myeloma.
Diamond B, Baughn L, Poorebrahim M, Poos AM, Lee H, Kaddoura M, Wiedmeier-Nutor JE, Durante M, Otteson G, Jevremovic D, Tang H, Fröhling S, Baertsch MA, Papadimitriou M, Ziccheddu B, Jelinek T, Lemoine C, Rak A, Green DJ, Landgren O, Neri P, Bergsagel L, Braggio E, Kumar S, Raab MS, Fonseca R, Bahlis N, Weinhold N, Maura F. Diamond B, et al. Among authors: papadimitriou m. Blood. 2025 Sep 25;146(13):1575-1585. doi: 10.1182/blood.2024028107. Blood. 2025. PMID: 40493883 Free PMC article.
Genomic and immune determinants of resistance to daratumumab-based therapy in relapsed refractory multiple myeloma.
Ziccheddu B, Giannotta C, D'Agostino M, Bertuglia G, Saraci E, Oliva S, Genuardi E, Papadimitriou M, Diamond B, Corradini P, Coffey D, Landgren O, Bolli N, Bruno B, Boccadoro M, Massaia M, Maura F, Larocca A. Ziccheddu B, et al. Among authors: papadimitriou m. Blood Cancer J. 2024 Jul 19;14(1):117. doi: 10.1038/s41408-024-01096-6. Blood Cancer J. 2024. PMID: 39030183 Free PMC article.
Temporal genomic dynamics shape clinical trajectory in multiple myeloma.
Maura F, Kaddoura M, Poos AM, Baughn LB, Ziccheddu B, Bärtsch MA, Cirrincione A, Maclachlan K, Chojnacka M, Diamond B, Papadimitriou M, Blaney P, John L, Reichert P, Huhn S, Gagler D, Zhang Y, Dogan A, Lesokhin AM, Davies F, Goldschmidt H, Fenk R, Weisel KC, Mai EK, Korde N, Morgan GJ, Rajkumar SV, Kumar S, Usmani S, Landgren O, Raab MS, Weinhold N. Maura F, et al. Among authors: papadimitriou m. Nat Genet. 2025 Sep;57(9):2203-2214. doi: 10.1038/s41588-025-02292-1. Epub 2025 Aug 20. Nat Genet. 2025. PMID: 40835892
Cancer quiescence: non-coding RNAs in the spotlight.
Soureas K, Papadimitriou MA, Panoutsopoulou K, Pilala KM, Scorilas A, Avgeris M. Soureas K, et al. Among authors: papadimitriou ma. Trends Mol Med. 2023 Oct;29(10):843-858. doi: 10.1016/j.molmed.2023.07.003. Epub 2023 Jul 27. Trends Mol Med. 2023. PMID: 37516569 Review.
Temporal Genomic Dynamics Shape Clinical Trajectory in Multiple Myeloma.
Maura F, Kaddoura M, Poos AM, Baughn LB, Ziccheddu B, Bärtsch MA, Cirrincione A, Maclachlan K, Chojnacka M, Diamond B, Papadimitriou M, Blaney P, John L, Reichert P, Huhn S, Gagler D, Zhang Y, Dogan A, Lesokhin AM, Davies F, Goldschmidt H, Fenk R, Weisel KC, Mai EK, Korde N, Morgan GJ, Rajkumar SV, Kumar S, Usmani S, Landgren O, Raab MS, Weinhold N. Maura F, et al. Among authors: papadimitriou m. bioRxiv [Preprint]. 2024 Sep 4:2024.08.30.610457. doi: 10.1101/2024.08.30.610457. bioRxiv. 2024. Update in: Nat Genet. 2025 Sep;57(9):2203-2214. doi: 10.1038/s41588-025-02292-1. PMID: 39282268 Free PMC article. Updated. Preprint.
Timing antigenic escape in multiple myeloma treated with T-cell redirecting immunotherapies.
Papadimitriou M, Ahn S, Diamond B, Lee H, McIntyre J, Truger M, Durante M, Ziccheddu B, Landgren O, Rasche L, Bahlis NJ, Neri P, Maura F. Papadimitriou M, et al. bioRxiv [Preprint]. 2024 May 26:2024.05.22.595383. doi: 10.1101/2024.05.22.595383. bioRxiv. 2024. Update in: Blood Cancer Discov. 2025 Sep 4. doi: 10.1158/2643-3230.BCD-25-0005. PMID: 38826396 Free PMC article. Updated. Preprint.
Genomics Define Malignant Transformation in Myeloma Precursor Conditions.
Maura F, Bergsagel PL, Ziccheddu B, Kumar S, Maclachlan K, Derkach A, Garces JJ, Firestone R, Braggio E, Asmann Y, Durante M, Diamond BT, Papadimitriou M, Hultcrantz M, Marella A, Castellano G, Maeda A, Lionetti M, Matera A, Pioggia S, Da Vià MC, de Magistris C, Leongamornlert D, DeAvila D, Sudalagunta PR, Canevarolo RR, Siegel EM, Agius P, Teer J, McPherson A, Yamashita Y, Silva AS, Blaney P, Baz R, Patel KK, Campbell P, Morgan G, Fonseca R, Landgren O, Orlowski RZ, Shain KH, Bolli N, Usmani S, Rajkumar SV. Maura F, et al. Among authors: papadimitriou m. J Clin Oncol. 2025 Oct 8:JCO2501733. doi: 10.1200/JCO-25-01733. Online ahead of print. J Clin Oncol. 2025. PMID: 41061199
146 results